Series A - Nectar
Investment Firm
Overview
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
Announced Date
Dec 20, 2022
Funding Type
Series A
Highlights
Location
New York, New York, United States, North America
Social
Participant Investors
3
| Investor Name |
|---|
 Obvious Ventures |
Round Details and Background
Nectar raised $16500000 on 2022-12-20 in Series A
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 16, 2022 |  Seed Round - Nectar | 2 | - | 8.0M |
| Dec 20, 2022 | Series A - Nectar | 3 | - | 16.5M |
Recent Activity
There is no recent news or activity for this profile.